<DOC>
	<DOCNO>NCT01017250</DOCNO>
	<brief_summary>The purpose study assess central nervous system ( CNS ) toxicity patient recurrent malignant glioma treat concurrent Avastin stereotactic radiosurgery ( SRS ) .</brief_summary>
	<brief_title>Radiosurgery Avastin Recurrent Malignant Gliomas</brief_title>
	<detailed_description>In pilot study , 15 human subject recurrent , unifocal malignant glioma 5-cm maximum dimension longer respond conventional chemotherapy able tolerate chemotherapy enrol . The primary endpoint study proportion patient experience CNS toxicity , secondary endpoint progression-free survival , overall survival , steroid dosage , development radionecrosis , quality life , objective radiographic response performance status .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>History malignant glioma ( WHO Grade III IV ) brain treated combination surgery , biochemotherapy conventionally fractionate external beam radiotherapy Radiotherapy complete least 6 month prior recurrence Age 18 year old New enlarge contrastenhancing and/or 18FDGavid nodule , least 1 cm diameter Estimated life expectancy 3 month longer Avastin therapy within 21 day start participation Contraindication Avastin therapy brain MRI Presence bleed diathesis coagulopathy History prior arterial thrombotic event , myocardial infarction , angina , CVA , TIA , CABG angioplasty stenting within 6 month . Inadequately control hypertension ( define systolic blood pressure New York Heart Association ( NYHA ) Grade II great congestive heart failure Clinically significant vascular disease Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior onset treatment Prior history hypertensive crisis hypertensive encephalopathy History abdominal fistula GI perforation within 6 month prior onset treatment Serious nonhealing wound , active ulcer untreated bone fracture Proteinuria demonstrate Urine Protein Creatinine ratio &gt; 1.0 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Recurrent</keyword>
</DOC>